ElectroCore (Nasdaq:ECOR) announced today that the U.S. Patent and Trademark office (USPTO) issued it a new nerve stimulation patent. The new patent (No. 11,839,764 ) relates to a system for stimulating a nerve target in the head or neck of a patient. It covers the treatment of various disorders, such as primary headache. It’s titled […]
U.S. Patent & Trademark Office (USPTO)
NeuroOne is pursuing drug delivery with neural probes
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it received a patent for drug delivery with neural probe devices. The United States Patent and Trademark Office (USPTO) issued the patent titled “Agent-Delivering Neural Probe Devices and Related Systems and Methods.” It covers novel electrodes that can operate as a standard neural electrode that delivers a treatment […]
HeartBeam wins AI-related patent for handheld vector ECG
HeartBeam (Nasaq:BEAT) announced today that it received a key patent relating to AI capabilities for its AIMIGo system. The U.S. Patent and Trademark Office (USPTO) issued the allowance for a patent titled “Hand Held Device for Automatic Cardiac Risk and Diagnostic Assessment.” The patent describes a system that combines recorded cardiac signals from AIMIGo with […]
ElectroCore expands patent portfolio for non-invasive vagus nerve stimulation tech
ElectroCore (Nasdaq:ECOR) announced today that it received patent issue notifications from the USPTO for three new patents. All three — issued on April 11 — relate to ElectroCore’s non-invasive vagus nerve stimulation (nVNS) technology. Rockaway, New Jersey-based ElectroCore received U.S. patents Nos. 11,623,078, 11,623,079 and 11,623,080. The first (11,623,078) is titled “Devices and Methods for […]
HeartBeam picks up patent for 12-lead ECG patch
HeartBeam (Nasdaq:BEAT) announced today that the U.S. Patent and Trademark Office issued a patent for its 12-lead electrocardiogram (ECG) patch. Santa Clara, California–based HeartBeam designed its ECG patch monitor for detecting acute coronary syndrome (ACS) and cardiac arrhythmia. The company said in a news release that the granted patent builds on its portfolio, enabling 12-lead […]
